Tixel i® (pronounced Tixel Eye): An Advanced Treatment for Evaporative Dry Eye

Tixel® is an FDA-cleared device offering a novel approach to treating evaporative dry eye disease caused by Meibomian Gland Dysfunction (MGD). MGD is recognized as the leading cause of dry eye cases.

Get Evaluated for Tixel Treatment

How Tixel® Works:

Powered by proprietary Thermo-Mechanical Action (TMA®) technology, Tixel® delivers controlled, short pulses of heat to the treatment area. This is achieved through a matrix of self-disinfecting titanium pyramids, applied with gentle pressure. Patients are treated three times in one month (every 2 weeks or so) to improve meibomian gland function.

Key Advantages of Tixel®:

Efficiency

A Tixel® treatment session is remarkably brief, typically lasting only 2 to 3 minutes for both eyes. This stands in stark contrast to other dry eye treatments, which can take up to an hour and may be associated with discomfort.
Proven Effectiveness
The efficacy of Tixel® has been scientifically validated through multiple clinical publications. This includes a robust multi-center study conducted in the USA, with a 6-month follow-up extension, demonstrating its positive outcomes for patients.
Established Safety Profile
The underlying Tixel® technology has been successfully utilized in aesthetic applications for several years. Its extensive use in aesthetics, where it. has consistently shown impressive results and a strong safety record, provides a solid foundation for its application in dry eye treatment. Notably, plastic surgeons observing patients treated with Tixel® for wrinkles, under-eye bags (festooning), and droopy eyelids also reported significant improvements in their patients’ dry eye symptoms.